STOPPFall (Screening Tool of Older Persons Prescriptions in older adults with high fall risk): a Delphi study by the EuGMS Task and Finish Group on Fall-Risk-Increasing Drugs
Jazyk angličtina Země Velká Británie, Anglie Médium print
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
33349863
PubMed Central
PMC8244563
DOI
10.1093/ageing/afaa249
PII: 6043386
Knihovny.cz E-zdroje
- Klíčová slova
- accidental falls, adverse effects, aged, deprescribing, fall-risk-increasing drugs, older people,
- MeSH
- delfská metoda MeSH
- léčivé přípravky * MeSH
- lékařské předpisy MeSH
- lidé MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- úrazy pádem * prevence a kontrola MeSH
- Check Tag
- lidé MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Evropa MeSH
- Názvy látek
- léčivé přípravky * MeSH
BACKGROUND: Healthcare professionals are often reluctant to deprescribe fall-risk-increasing drugs (FRIDs). Lack of knowledge and skills form a significant barrier and furthermore, there is no consensus on which medications are considered as FRIDs despite several systematic reviews. To support clinicians in the management of FRIDs and to facilitate the deprescribing process, STOPPFall (Screening Tool of Older Persons Prescriptions in older adults with high fall risk) and a deprescribing tool were developed by a European expert group. METHODS: STOPPFall was created by two facilitators based on evidence from recent meta-analyses and national fall prevention guidelines in Europe. Twenty-four panellists chose their level of agreement on a Likert scale with the items in the STOPPFall in three Delphi panel rounds. A threshold of 70% was selected for consensus a priori. The panellists were asked whether some agents are more fall-risk-increasing than others within the same pharmacological class. In an additional questionnaire, panellists were asked in which cases deprescribing of FRIDs should be considered and how it should be performed. RESULTS: The panellists agreed on 14 medication classes to be included in the STOPPFall. They were mostly psychotropic medications. The panellists indicated 18 differences between pharmacological subclasses with regard to fall-risk-increasing properties. Practical deprescribing guidance was developed for STOPPFall medication classes. CONCLUSION: STOPPFall was created using an expert Delphi consensus process and combined with a practical deprescribing tool designed to optimise medication review. The effectiveness of these tools in falls prevention should be further evaluated in intervention studies.
Department of Clinical Gerontology King's College London England UK
Department of Internal Medicine and Paediatrics Ghent University Ghent Belgium
Faculty of Industrial Design Engineering Delft University of Technology Delft The Netherlands
Geriatria Accettazione Geriatrica e Centro di ricerca per l'invecchiamento IRCCS INRCA Ancona Italy
Health Care of Older People East Kent Hospitals University NHS Foundation Trust Canterbury Kent UK
Outpatient Geriatric Assessment Unit Henry Dunant Hospital Center Athens Greece
Research Department of Primary Care and Population Health University College London London UK
School of Pharmacy University of Eastern Finland Kuopio Finland
Servicio de Geriatría Hospital Universitario Ramón y Cajal Madrid Spain
Unit of Innovation and Organization Navarre Health Service Pamplona Spain
Zobrazit více v PubMed
Centers for Disease Control and Prevention . Injury Prevention & Control. Keep on your feet - Preventing Older Adult Falls. https://www.cdc.gov/injury/features/older-adult-falls/index.html. (20 April 2020, date last accessed).
de Vries M, Seppala LJ, Daams JG et al. Fall-risk-increasing drugs: a systematic review and meta-analysis: I. cardiovascular drugs. J Am Med Dir Assoc 2018; 19: 371 e1–9. PubMed
Seppala LJ, Wermelink A, de Vries M et al. Fall-risk-increasing drugs: a systematic review and meta-analysis: II. Psychotropics. J Am Med Dir Assoc 2018; 19: 371 e11–7. PubMed
Seppala LJ, van de Glind EMM, Daams JG et al. Fall-risk-increasing drugs: a systematic review and meta-analysis: III. Others. J Am Med Dir Assoc 2018; 19: 372 e1–8. PubMed
Seppala LJ, van der Velde N, Masud T et al. EuGMS task and finish group on fall-risk-increasing drugs (FRIDs): position on knowledge dissemination, management, and future research. Drugs Aging 2019; 36: 299–307. PubMed PMC
Laflamme L, Monarrez-Espino J, Johnell K et al. Type, number or both? A population-based matched case-control study on the risk of fall injuries among older people and number of medications beyond fall-inducing drugs. PLoS One 2015; 10: e0123390. PubMed PMC
Gillespie LD, Robertson MC, Gillespie WJ et al. Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev 2012; Cd007146. PubMed PMC
Cameron ID, Dyer SM, Panagoda CE et al. Interventions for preventing falls in older people in care facilities and hospitals. Cochrane Database Syst Rev 2018; 9: CD005465. doi: 10.1002/14651858.CD005465.pub4. PubMed DOI PMC
Summary of the Updated American Geriatrics Society . British geriatrics society clinical practice guideline for prevention of falls in older persons. J Am Geriatr Soc 2011; 59: 148–57. PubMed
Valbreventie.be. Expertisecentrum Valpreventie Vlaanderen . Valpreventie bij thuiswonende ouderen. In: Flamish guideline Falls prevention in older people living at home, 2017, Leuven, http://www.valpreventie.be.
Federatie Medisch Specialisten . Richtlijn Preventie van valincidenten bij ouderen. In: Dutch guideline prevention of falls in older people, 2017, https://richtlijnendatabase.nl/richtlijn/preventie_van_valincidenten_bij_ouderen/startpagina_-_preventie_van_valincidenten.html (20 March 2020, date last accessed).
NICE . NICE guidelines: falls assessment and prevention of falls in older people (CG161), National Institute for Health and Care Excellence: Manchester, 2013. PubMed
Prevenzione delle cadute da incidente domestico negli anziani (Italian guideline Falls prevention in older people), PROGRAMMA NAZIONALE LINEE GUIDA: Roma, 2009.
Strategy to Prevent Falls and Fractures in Ireland’s Ageing Population . Report of the National Steering Group on the Prevention of Falls in Older People and the Prevention and Management of Osteoporosis throughout Life, The Health Service Executive, Department of Health and Children and National Council on Ageing and Older people: Dublin, 2008.
Documento de consenso sobre prevención de fragilidad y caídas en la persona mayor (Spanish consensus Document on prevention of frailty and falls in the older person), MINISTERIO DE SANIDAD, SERVICIOS SOCIALES E IGUALDAD CENTRO DE PUBLICACIONES: Madrid, 2014.
Sundhedstyrelssen . National klinisk retninglijne for forebyggelse af fald hos ældre (Danish national clinical guideline for the prevention of falls in elderly people), Sundhedsstyrelsen: København, 2018.
Évaluation et prise en charge des personnes âgées faisant des chutes répétées . French guideline Assessment and management of elderly people having recurrent falls, Haute Autorité de Santé: Saint-Denis, 2009.
O'Mahony D, O'Sullivan D, Byrne S et al. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing 2015; 44: 213–8. PubMed PMC
American Geriatrics Society . American Geriatrics Society 2015 updated beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2015; 63: 2227–46. PubMed
Pazan F, Wehling M. The FORTA (fit fOR the aged) app as a clinical tool to optimize complex medications in older people. J Am Med Dir Assoc 2017; 18: 893. PubMed
Bahat G, Ilhan B, Erdogan T et al. Turkish inappropriate medication use in the elderly (TIME) criteria to improve prescribing in older adults: TIME-to-STOP/TIME-to-START. European Geriatric Medicine 2020; 11: 491–8. PubMed PMC
Michalek C, Wehling M, Schlitzer J et al. Effects of “fit fOR the aged” (FORTA) on pharmacotherapy and clinical endpoints—a pilot randomized controlled study. Eur J Clin Pharmacol 2014; 70: 1261–7. PubMed
Frankenthal D, Lerman Y, Kalendaryev E et al. Intervention with the screening tool of older persons potentially inappropriate prescriptions/screening tool to alert doctors to right treatment criteria in elderly residents of a chronic geriatric facility: a randomized clinical trial. J Am Geriatr Soc 2014; 62: 1658–65. PubMed
Curtin D, Byrne S, O’Mahony D. Identifying Explicit Criteria for the Prevention of Falls. In: Huang AR, Mallet L, eds. Medication-related falls in older people; Springer International Publishing: Switzerland, 179–88.
Gallagher P, Ryan C, Byrne S et al. STOPP (screening tool of older Person's prescriptions) and START (screening tool to alert doctors to right treatment). Consensus validation. Int J Clin Pharmacol Ther 2008; 46: 72–83. PubMed
EuGMS . Research & Cooperation. Special Interest Groups. Pharmacology. https://www.eugms.org/research-cooperation/special-interest-groups/pharmacology.html. (20 March 2020, date last accessed).
EuGMS . Research & Cooperation. Special Interest Groups. Falls and Fractures. https://www.eugms.org/research-cooperation/special-interest-groups/falls-and-fractures.html. 20 March 2020, date last accessed.
Reeve E, Shakib S, Hendrix I et al. Review of deprescribing processes and development of an evidence-based, patient-centred deprescribing process. Br J Clin Pharmacol 2014; 78: 738–47. PubMed PMC
Iyer S, Naganathan V, McLachlan AJ et al. Medication withdrawal trials in people aged 65 years and older. Drugs Aging 2008; 25: 1021–31. PubMed
EuGMS . Research & Cooperation. Task & Finish Groups. FRID - Fall Risk Increasing Drugs. https://www.eugms.org/research-cooperation/task-finish-groups/frid-fall-risk-increasing-drugs.html. 20 August 2020, date last accessed.
Reeve E, Low L-F, Shakib S et al. Development and validation of the revised patients’ attitudes towards Deprescribing (rPATD) questionnaire: versions for older adults and caregivers. Drugs Aging 2016; 33: 913–28. PubMed
Morin L, Calderon Larrañaga A, Welmer A-K et al. Polypharmacy and injurious falls in older adults: a nationwide nested case-control study. Clin Epidemiol 2019; 11: 483–93. PubMed PMC